Juan J. González‐Aguilera

Author

Also Known As

J J González-Aguilera, J. Gonzalez-Aguilera, J. J. Gonzalez-Aguilera, J. J. Gonzalez‐Aguilera, J. J. González-Aguilera, J. J. González‐Aguilera, J.J. González-Aguilera, Juan González-Aguilera, Juan J. González-Aguilera, Juan J. González‐Aguilera

Publications

493

Citations

H-Index

Concepts

All Affiliations

Universidad Autónoma de Madrid Hospital Universitario de Canarias Hospital Universitario de Getafe Hospital Central de la Cruz Roja San José y Santa Adela Centre for Biomedical Network Research on Rare Diseases

About

Juan J. González‐Aguilera is an author at Universidad Autónoma de Madrid specializing in medicine, cancer genetics, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	262
2	Pathology	8	8	237
3	Public Health	3	3	120
4	Cancer Epidemiology	3	3	120
5	Epidemiology	1	1	32

Juan J. González‐Aguilera

Publications

347

Citations

H-Index

Page 1

	Year	Citations
Association of polymorphisms MTHFR C677T and A1298C with risk of colorectal cancer, genetic and epigenetic characteristic of tumors, and response to chemotherapy Antonia M. Fernández‐Peralta, Lydia Daimiel, Nargisse Nejda, International Journal of Colorectal Disease Tumor BiologyCancer RiskCancer EpidemiologyMedicineGenetics	2009	59
Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome Vicente Medina‐Arana, L. Delgado, Lucía Gómez González, Familial Cancer Neuro-oncologyTumoral PathologyAdrenocortical CarcinomaSurgical PathologyPathology	2011	35
Simultaneous Mutations in K-ras and TP53 Are Indicative of Poor Prognosis in Sporadic Colorectal Cancer Juan J. González‐Aguilera, Soledad Oliart, M Moreno Azcoita, American Journal of Clinical Oncology	2004	32
Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer Daniel Iglesias, Nargisse Nejda, M Moreno Azcoita, Cancer Causes & Control EpidemiologyCancer RiskCancer EpidemiologyCox2 -765GMedicine	2009	32
Significance of mutations in TGFBR2 and BAX in neoplastic progression and patient outcome in sporadic colorectal tumors with high-frequency microsatellite instability Antonia M. Fernández‐Peralta, Nargisse Nejda, Soledad Oliart, Cancer Genetics and Cytogenetics High-frequency Microsatellite InstabilitySomatic VariantMedicineSporadic Colorectal TumorsNeoplastic Progression	2005	30
A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer Nargisse Nejda, Daniel Iglesias, M Moreno Azcoita, Cancer Genetics and Cytogenetics Cancer RiskCancer EpidemiologyCancer PathologyMedicineGenetic Epidemiology	2009	29
Further Associations between Mutations and Polymorphisms in the<i>ABCA4</i>Gene: Clinical Implication of Allelic Variants and Their Role as Protector/Risk Factors Jana Aguirre-Lambán, Juan J. González‐Aguilera, Rosa Riveiro-Álvarez, Investigative Ophthalmology & Visual Science	2011	26
RIS1, a gene with trinucleotide repeats, is a target in the mutator pathway of colorectal carcinogenesis Daniel Iglesias, Antonia M. Fernández‐Peralta, Nargisse Nejda, Cancer Genetics and Cytogenetics Systems BiologyOncogenic AgentGeneticsColorectal CancerMutator Pathway	2006	25
New founding mutation in MSH2 associated with hereditary nonpolyposis colorectal cancer syndrome on the Island of Tenerife Vicente Medina‐Arana, Ysamar Barrios, Antonia M. Fernández‐Peralta, Cancer Letters Somatic VariantGenetic DisorderMedicineGeneticsColorectal Cancer	2006	21
Intron splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer Marta Palicio, Ignacio Blanco, Silvia Tórtola, British Journal of Cancer	2000	17

Page 1